Disease | N. SNPs d | DSI v | DPI v | Chr | Position | Consequence | Alleles | Class | AFEXOME | AFGENOME | Score vda | EI vda | N. PMIDs | First Ref. | Last Ref. | ||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Diabetes Mellitus, Non-Insulin-Dependent
|
2672 | 0.667 | 0.480 | 10 | 113049143 | intron variant | G/A;T | snv | 0.900 | 0.908 | 65 | 2006 | 2020 | ||||||
Diabetes
|
710 | 0.667 | 0.480 | 10 | 113049143 | intron variant | G/A;T | snv | 0.090 | 1.000 | 9 | 2006 | 2016 | ||||||
Diabetes Mellitus
|
824 | 0.667 | 0.480 | 10 | 113049143 | intron variant | G/A;T | snv | 0.090 | 1.000 | 9 | 2006 | 2016 | ||||||
Gestational Diabetes
|
224 | 0.667 | 0.480 | 10 | 113049143 | intron variant | G/A;T | snv | 0.070 | 0.857 | 7 | 2007 | 2019 | ||||||
Breast Carcinoma
|
2793 | 0.667 | 0.480 | 10 | 113049143 | intron variant | G/A;T | snv | 0.050 | 1.000 | 5 | 2008 | 2018 | ||||||
Malignant neoplasm of breast
|
3417 | 0.667 | 0.480 | 10 | 113049143 | intron variant | G/A;T | snv | 0.050 | 1.000 | 5 | 2008 | 2018 | ||||||
Colorectal Carcinoma
|
1962 | 0.667 | 0.480 | 10 | 113049143 | intron variant | G/A;T | snv | 0.030 | 1.000 | 3 | 2016 | 2019 | ||||||
Impaired glucose tolerance
|
81 | 0.667 | 0.480 | 10 | 113049143 | intron variant | G/A;T | snv | 0.030 | 1.000 | 3 | 2006 | 2011 | ||||||
Malignant neoplasm of colon and/or rectum
|
502 | 0.667 | 0.480 | 10 | 113049143 | intron variant | G/A;T | snv | 0.030 | 1.000 | 3 | 2016 | 2019 | ||||||
Metabolic Syndrome X
|
591 | 0.667 | 0.480 | 10 | 113049143 | intron variant | G/A;T | snv | 0.030 | 0.667 | 3 | 2009 | 2018 | ||||||
Polycystic Ovary Syndrome
|
363 | 0.667 | 0.480 | 10 | 113049143 | intron variant | G/A;T | snv | 0.030 | 1.000 | 3 | 2014 | 2015 | ||||||
Obesity
|
1111 | 0.667 | 0.480 | 10 | 113049143 | intron variant | G/A;T | snv | 0.020 | 1.000 | 2 | 2009 | 2011 | ||||||
Breast Cancer, Familial
|
91 | 0.667 | 0.480 | 10 | 113049143 | intron variant | G/A;T | snv | 0.010 | 1.000 | 1 | 2006 | 2006 | ||||||
Carcinogenesis
|
355 | 0.667 | 0.480 | 10 | 113049143 | intron variant | G/A;T | snv | 0.010 | 1.000 | 1 | 2013 | 2013 | ||||||
Carcinoma of lung
|
1204 | 0.667 | 0.480 | 10 | 113049143 | intron variant | G/A;T | snv | 0.010 | 1.000 | 1 | 2018 | 2018 | ||||||
Coronary Artery Disease
|
1577 | 0.667 | 0.480 | 10 | 113049143 | intron variant | G/A;T | snv | 0.010 | 1.000 | 1 | 2011 | 2011 | ||||||
Diabetes in youth
|
2 | 0.667 | 0.480 | 10 | 113049143 | intron variant | G/A;T | snv | 0.010 | 1.000 | 1 | 2011 | 2011 | ||||||
Diabetes Mellitus, Insulin-Dependent
|
954 | 0.667 | 0.480 | 10 | 113049143 | intron variant | G/A;T | snv | 0.010 | 1.000 | 1 | 2010 | 2010 | ||||||
Fasting blood glucose measurement
|
212 | 0.667 | 0.480 | 10 | 113049143 | intron variant | G/A;T | snv | 0.700 | 1.000 | 1 | 2012 | 2012 | ||||||
Fasting blood sugar result
|
113 | 0.667 | 0.480 | 10 | 113049143 | intron variant | G/A;T | snv | 0.700 | 1.000 | 1 | 2012 | 2012 | ||||||
Hyperlipidemia, Familial Combined
|
28 | 0.667 | 0.480 | 10 | 113049143 | intron variant | G/A;T | snv | 0.010 | 1.000 | 1 | 2008 | 2008 | ||||||
Malignant neoplasm of lung
|
1142 | 0.667 | 0.480 | 10 | 113049143 | intron variant | G/A;T | snv | 0.010 | 1.000 | 1 | 2018 | 2018 | ||||||
Malignant neoplasm of prostate
|
1082 | 0.667 | 0.480 | 10 | 113049143 | intron variant | G/A;T | snv | 0.010 | 1.000 | 1 | 2008 | 2008 | ||||||
Malignant neoplasm of stomach
|
615 | 0.667 | 0.480 | 10 | 113049143 | intron variant | G/A;T | snv | 0.010 | 1.000 | 1 | 2016 | 2016 | ||||||
Premature adrenarche
|
11 | 0.667 | 0.480 | 10 | 113049143 | intron variant | G/A;T | snv | 0.010 | 1.000 | 1 | 2009 | 2009 |